Mechanisms underlying cerebrovascular effects of cigarette smoking in rats in vivo

Stroke

Volumn 29, Issue 8, 1998, Pages 1656-1665

  Iida, Mami ^a   Iida, Hiroki ^a   Dohi, Shuji ^a   Takenaka, Motoyasu ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral vessels; Cigarette smoking; Microcirculation; Nicotine; Rats

Indexed keywords

CIGARETTE SMOKE; GLIBENCLAMIDE; MECAMYLAMINE; N(G) NITROARGININE METHYL ESTER; NICOTINE; NITRIC OXIDE; POTASSIUM CHANNEL; POTASSIUM ION; PROPRANOLOL; SERATRODAST; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY TONE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; BRAIN BLOOD VESSEL; BRAIN CIRCULATION; CIGARETTE SMOKING; CONTROLLED STUDY; MALE; NONHUMAN; PIA ARTERY; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE; VASOCONSTRICTION; VASODILATATION;

EID: 0031928632     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.8.1656     Document Type: Article

References (52)

1. Kannel WB. Current status of epidemiology of brain infarction associated with occlusive arterial disease. Stroke. 1971;2:295-318.
2. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298:789-794.
3. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: The Framingham Study. JAMA. 1988;259:1025-1029.
4. Rogers RL, Meyer JS, Shaw TG, Mortel KF, Hardenberg MA, Zaid RR. Cigarette smoking decreases cerebral blood flow suggesting increased risk for stroke. JAMA. 1983;250:2796-2800.
5. Kubota K, Yamaguchi T, Abe Y, Fujiwara T, Hatazawa J, Matsuzawa T. Effects of smoking on regional cerebral blood flow in neurologically normal subjects. Stroke. 1983;14:720-724.
6. Skinhøj E, Diesen J, Paulson OB. Influence of smoking and nicotine on cerebral blood flow and metabolic rate of oxygen in man. J Appl Physiol. 1973;35:820-822.
7. Wechsler RL. Effects of cigarette smoking and intravenous nicotine on human brain. Fed Proc. 1958;17:169. Abstract.
8. Cruickshank JM, Neil-Dwyer G, Dorrance DE, Haves Y, Patel S. Acute effects of smoking on blood pressure and cerebral blood flow. J Hum Hypertens. 1989;3:443-449.
9. Wynder EL, Hoffmann D. Tobacco and health: a social challenge. N Engl J Med. 1979;300:894-903.
10. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol. 1994;266: H874-H880.
11. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;319:1318-1330.
12. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976;295:573-577.
13. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Bo AD, Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation. 1994;90:248-253.
14. Taylar P. Ganglionic stimulating drugs. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, NY: Pergamon Press; 1990:166-186.
15. Mulle C, Vidal C, Benoit P, Changeux JP. Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system. J Neurosci. 1991;11:2588-2597.
16. Gillberg PG, Hartvig P, Gordh T, Sottile A, Jansson I, Archer T, Post C. Behavioral effects after intrathecal administration of cholinergic receptor agonists in rat. Psychopharmacology. 1990;100:464-469.
17. Martin TJ, Suchocki J, May EL, Martin BR. Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine. J Pharmacol Exp Ther. 1990;254:45-51.
18. Stolerman IP, Pratt JA, Garcha HS, Giardini V, Kumar R. Nicotine cue in rats analyzed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology. 1983;22:1029-1037.
19. Crystal GJ, Downey F, Adkins TP, Bashour FA. Regional blood flow in canine brain during nicotine infusion: effect of autonomic blocking drugs. Stroke. 1983;14:941-947.
20. Scheurink AJW, Steffens AB, Bouritius H, Dreteler GH, Bruntink R, Remie R, Zaagsma J. Sympathoadrenal influence on glucose, FFA, and insulin levels in exercising rats. Am J Physiol. 1989;256:R161-R168.
21. Dohi S, Jones MD Jr, Hudak ML, Traystman RJ. Effects of cocaine on pial arterioles in cats. Stroke. 1990;21:1710-1714.
22. Ishiyama T, Dohi S, Iida H, Akamatsu S, Ohta S, Shimonaka H. Mechanisms of vasodilation of cerebral vessels induced by potassium channel opener nicorandil in canine in vivo experiments. Stroke. 1994;25: 1644-1650.
23. Lee WS, Kwon YK, Yu SS, Rhim BY, Hong KW. Disturbances in autoregulatory responses of rat pial arteries by sulfonylureas. Life Sci. 1993;52:1527-1534.
24. Nichols CG, Lederer WJ. Adenosine triphosphate-sensitive potassium channels in cardiovascular system. Am J Physiol. 1991;261: H1675-H1686.
25. + channel openers, diazoxine and cromakalim, and their inhibition by glibenclamide. J Pharmacol Exp Ther. 1989;250:261-271.
26. Moreau R, Kumeichi H, Kirstetter P, Yang S, Aupetit-Faisant B, Cailmail S, Lebrec D. Effects of glibenclamide on systemic and splanchnic haemodynamics in conscious rats. Br J Pharmacol. 1994;112:649-653.
27. Narishige T, Egashira K, Akatsuka Y, Imamura Y, Takahashi T, Kasuya H, Takeshita A. Glibenclamide prevents coronary vasodilation induced by β1-adrenoceptor stimulation in dogs. Am J Physiol. 1994;266: H84-H92.
28. Faraci FM, Brian JE. Nitric oxide and the cerebral circulation. Stroke. 1994;25:692-703.
29. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288: 373-376.
30. Dirnagl U, Lindauer U, Villringer A. Role of nitric oxide in the coupling of cerebral blood flow to neural activation in rats. Neurosci Lett. 1993; 149:43-46.
31. Prado R, Watson BD, Kuluz J, Dietrich WD. Endothelium-derived nitric-oxide synthase inhibition: effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke. 1992;23:1118-1123.
32. Pelligrino DA, Koenig H, Albrecht RF. Nitric oxide synthesis and regional cerebral blood flow responses to hypercapnia and hypoxia in the rat. J Cereb Blood Flow Metab. 1993;13:80-87.
33. Iadecola C, Xu X, Zhang F, Hu J, El-Fakahany EE. Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine methyl ester. Neurochem Res. 1994;19:501-505.
34. Balfour DJ. Neural mechanisms underlying nicotine dependence. Addiction. 1994;89:1419-1423.
35. Perkins KA, Grobe JE, Fonte C, Goettler J, Caggiula AR, Reynolds WA, Stiller RL, Scierka A, Jacob RG. Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther. 1994;270:628-638.
36. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88:2149-2155.
37. Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, Buhler FR. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation. 1994;90:27-34.
38. Traystman RJ, Fitzgerald RS, Loscutoff. Cerebral circulatory responses to arterial hypoxia in normal and chemodenervated dogs. Circ Res. 1978; 42:649-657.
39. Koehler RC, Jones MD Jr, Traystman RJ. Cerebral circulatory response to carbon monoxide and hypoxic hypoxia in the lamb. Am J Physiol. 1982;243:H27-H32.
40. 2 in anesthetized chronically diabetic doss. Am J Physiol. 1993;264:H1069-H1075.
41. Hong JL, Lee LY. Cigarette smoke-induced bronchoconstriction: causative agents and role of thromboxane receptors. J Appl Physiol. 1996;81:2053-2059.
42. Goerre S, Staehli C, Shaw S, Luscher TF. Effect of cigarette smoking and nicotine on plasma endothelin-1 levels. J Cardiovasc Pharmacol. 1995; 26:5236-5238.
43. Haak T, Jungmann E, Raab C, Usadel KH. Elevated endothelin-1 levels after cigarette smoking. Metabolism. 1994;43:267-269.
44. Ribeiro EB, Bettiker RL, Bogdanov M, Wurtman RJ. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 1993; 621:311-318.
45. Ashida Y, Matsumoto T, Kuriki H, Shiraishi M, Kato K, Terao S. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. Prostaglandins. 1989;38:91-112.
46. 2 receptor by an anti-asthmatic agent AA-2414. Biol Pharm Bull. 1994;17:383-385.
47. Hardeho JB, Ouman C. Effects of neurotransmitters on cerebral blood vessels and cerebral circulation. In: Mraovitch S, Sercombe R, eds. Neurophysiological Basis of Cerebral Blood Flow Control: An Introduction. London, UK: John Libbey & Co Ltd; 1996:263-284.
48. Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JL Jr. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol. 1978;234:H371-H383.
49. Harper SL, Bohlen HG, Rubin MJ. Arterial and microvascular contributions to cerebral cortical autoregulation in rats. Am J Physiol. 1984; 246:H17-H24.
50. Russel MAH, Jarvis M, Iyer R, Feyerabend C. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J. 1980;280:972-976.
51. Pomerleau OF. Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. Am J Med. 1992;93(suppl 1A):2S-7S.
52. Moreyra AE, Lacy CR, Wilson AC, Kumar A, Kostis JB. Arterial blood nicotine concentration and coronary vasoconstrictive effect of low-nicotine cigarette smoking. Am Heart J. 1992;124:392-397.